The fosamprenavir with ritonavir twice daily regimen and the lopinavir / ritonavir twice daily regimen showed similar immunological improvements through 48 weeks of treatment as measured by median change from baseline in CD4+ cell count (fosamprenavir with ritonavir twice daily: